Drug Type Small molecule drug |
Synonyms (+)-Ajmaline, Ajmalin, Ajmaline (JP17) + [6] |
Target |
Action blockers |
Mechanism SCNA blockers(Sodium voltage-gated channel alpha subunits blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC20H26N2O2 |
InChIKeyCJDRUOGAGYHKKD-IWMNNKGHSA-N |
CAS Registry4360-12-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Arrhythmias, Cardiac | - | - | - |
Not Applicable | - | Ajmaline infusion protocol | qyxyhndtty(pyxipsrurd) = txyjrylfge llvyfwjzos (gdkfuhbfrt ) | - | 02 Sep 2024 | ||
Ajmaline bolus protocol | qyxyhndtty(pyxipsrurd) = ccasnlujdx llvyfwjzos (gdkfuhbfrt ) | ||||||
Not Applicable | - | - | Ajmaline infusion protocol | vhsyydbokx(rdokfmvuwm) = sehoetcnbr iegyltadmi (lpxxuizrfj ) | - | 13 May 2024 | |
Ajmaline bolus protocol | vhsyydbokx(rdokfmvuwm) = mozbtcvtut iegyltadmi (lpxxuizrfj ) | ||||||
Not Applicable | 101 | (Group A (infusion protocol)) | ptpwolfmqj(dskiwgivsc) = jdtgxcjvws dejcsehlnz (ragyvviinq ) View more | Positive | 11 May 2024 | ||
(Group B (bolus protocol)) | ptpwolfmqj(dskiwgivsc) = nxkgaduewy dejcsehlnz (ragyvviinq ) View more | ||||||
Not Applicable | - | 100 | nzelwkwapq(jtldcafzkk) = brqkajgtdl xublqpfwok (miarxrsrae ) View more | - | 16 Apr 2023 | ||
Not Applicable | 1,392 | norpqwpann(leuxbwumuk) = iedfuilzcn yzufjkadmk (iuyqlbkdag ) View more | - | 28 Aug 2020 |